ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Harold Amos Receives Drew Medical Prize

October 27, 1989

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

August 12, 1988

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986